Cite

HARVARD Citation

    Luke, J. (2019). Comprehensive Clinical Trial Data Summation for BRAF‐MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma. Oncologist. pp. e1197-e1211. [Online]. 
  
Back to record